These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1592095)

  • 1. Plasmodium falciparum: rapid detection of dihydrofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine.
    Gyang FN; Peterson DS; Wellems TE
    Exp Parasitol; 1992 Jun; 74(4):470-2. PubMed ID: 1592095
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
    Foote SJ; Galatis D; Cowman AF
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3014-7. PubMed ID: 2183221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum.
    Basco LK; Eldin de Pécoulas P; Wilson CM; Le Bras J; Mazabraud A
    Mol Biochem Parasitol; 1995 Jan; 69(1):135-8. PubMed ID: 7723784
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion.
    Eldin de Pécoulas P; Basco LK; Abdallah B; Djé MK; Le Bras J; Mazabraud A
    Exp Parasitol; 1995 May; 80(3):483-7. PubMed ID: 7729483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
    Peterson DS; Milhous WK; Wellems TE
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea.
    Reeder JC; Rieckmann KH; Genton B; Lorry K; Wines B; Cowman AF
    Am J Trop Med Hyg; 1996 Aug; 55(2):209-13. PubMed ID: 8780462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum: mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient.
    Zindrou S; Nguyen PD; Nguyen DS; Sköld O; Swedberg G
    Exp Parasitol; 1996 Oct; 84(1):56-64. PubMed ID: 8888732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon.
    Peterson DS; Di Santi SM; Povoa M; Calvosa VS; Do Rosario VE; Wellems TE
    Am J Trop Med Hyg; 1991 Oct; 45(4):492-7. PubMed ID: 1951858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Presence of pyrimethamine and cycloguanil resistance genotype in West Africa? Evidence of a single mutation 59Arg in the dhfr gene of Plasmodium falciparum].
    Pinheiro L; Rosário VE
    Acta Med Port; 2003; 16(4):235-8. PubMed ID: 22226208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains].
    Basco LK; Le Bras J
    Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.
    Japrung D; Leartsakulpanich U; Chusacultanachai S; Yuthavong Y
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4356-60. PubMed ID: 17875995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biochemical and genetic model for parasite resistance to antifolates. Toxoplasma gondii provides insights into pyrimethamine and cycloguanil resistance in Plasmodium falciparum.
    Reynolds MG; Roos DS
    J Biol Chem; 1998 Feb; 273(6):3461-9. PubMed ID: 9452469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa.
    Plowe CV; Djimde A; Bouare M; Doumbo O; Wellems TE
    Am J Trop Med Hyg; 1995 Jun; 52(6):565-8. PubMed ID: 7611566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling of wild-type and antifolate resistant mutant Plasmodium falciparum DHFR.
    Delfino RT; Santos-Filho OA; Figueroa-Villar JD
    Biophys Chem; 2002 Aug; 98(3):287-300. PubMed ID: 12128181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum: three amino acid changes in the dihydrofolate reductase of a pyrimethamine-resistant mutant.
    Inselburg J; Bzik DJ; Li WB
    Exp Parasitol; 1988 Dec; 67(2):361-3. PubMed ID: 3056741
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of a semi-nested PCR diagnosis test to evaluate antifolate resistance of Plasmodium falciparum isolates.
    Eldin de Pecoulas P; Abdallah B; Dje MK; Basco LK; le Bras J; Mazabraud A
    Mol Cell Probes; 1995 Dec; 9(6):391-7. PubMed ID: 8808309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya.
    Khan B; Omar S; Kanyara JN; Warren-Perry M; Nyalwidhe J; Peterson DS; Wellems T; Kaniaru S; Gitonga J; Mulaa FJ; Koech DK
    Trans R Soc Trop Med Hyg; 1997; 91(4):456-60. PubMed ID: 9373654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
    Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance.
    Santos-Filho OA; de Alencastro RB; Figueroa-Villar JD
    Biophys Chem; 2001 Jul; 91(3):305-17. PubMed ID: 11551441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.